(Press-News.org) ORLANDO, Fla., April 2, 2013 – Many recent studies have suggested that obesity is associated with chronic inflammation in fat tissues. Researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have discovered that an imbalance between an enzyme called neutrophil elastase and its inhibitor causes inflammation, obesity, insulin resistance, and fatty liver disease. This enzyme is produced by white blood cells called neutrophils, which play an important role in the body's immune defense against bacteria. The researchers found that obese humans and mice have increased neutrophil elastase activity and decreased levels of α1-antitrypsin, a protein that inhibits the elastase. When the team reversed this imbalance in a mouse model and fed them a high-fat diet, the mice were resistant to body weight gain, insulin resistance (a precursor to type 2 diabetes), and fatty liver disease. Their study appears April 2 in Cell Metabolism.
"The imbalance between neutrophil elastase and its inhibitor, α1-antitrypsin, is likely an important contributing factor in the development of obesity, inflammation, and other health problems. Shifting this balance—by either reducing one or increasing the other—could provide a new therapeutic approach to preventing and treating obesity and several obesity-related conditions," said Zhen Jiang, Ph.D., assistant professor in Sanford-Burnham's Diabetes and Obesity Research Center at Lake Nona, Orlando and senior author of the study.
What happens when you reduce neutrophil elastase levels
This study began when Jiang and his team noticed that neutrophil elastase levels are particularly high and α1-antitrypsin levels are low in a mouse model of obesity. Then they saw the same thing in blood samples from human male volunteers.
To further probe this curious neutrophil elastase-obesity relationship, the researcher turned once again to mouse models. They found that mice completely lacking the neutrophil elastase enzyme don't get as fat as normal mice, even when fed a high-fat diet. Those mice were also protected against inflammation, insulin resistance, and fatty liver. The same was true in a mouse model genetically modified to produce human α1-antitrypsin, which inhibits neutrophil elastase.
Normal mice on a high-fat diet were also protected against inflammation, insulin resistance, and fatty liver when they were given a chemical compound that inhibits neutrophil elastase. This finding helps validate the team's conclusions about neutrophil elastase's role in inflammation and metabolism and also suggests that a medicinal drug could someday be developed to target this enzyme.
Mechanism: how neutrophil elastase influences inflammation and metabolism
How do high neutrophil elastase levels increase inflammation and cause weight gain and other metabolic problems?
Jiang and his team began connecting the mechanistic dots. They discovered that neutrophil elastase-deficient mice have increased levels of several factors, including adiponectin, AMPK, and fatty acid oxidation. These are known for their roles in increasing energy expenditure, thus helping the body burn excess fat.
INFORMATION:
This research was funded by a Sanford-Burnham start-up fund, the American Diabetes Association (grant 7-11-BS-72), U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK094025), and U.K. Medical Research Council (grant U117512772).
The study was co-authored by Virginie Mansuy-Aubert, Sanford-Burnham; Qiong L. Zhou, Sanford-Burnham; Xiangyang Xie, Sanford-Burnham; Zhenwei Gong, Sanford-Burnham; Jun-Yuan Huang, Sanford-Burnham; Abdul R. Khan, Sanford-Burnham, National Institute for Biotechnology and Genetic Engineering, Pakistan; Gregory Aubert, Sanford-Burnham; Karla Candelaria, Sanford-Burnham; Shantele Thomas, Sanford-Burnham; Dong-Ju Shin, Sanford-Burnham; Sarah Booth, U.K. National Institute of Medical Research; Shahid M. Baig, National Institute for Biotechnology and Genetic Engineering, Pakistan; Ahmed Bilal, Allied Hospital, Punjab Medical College; Daehee Hwang, Institute for Systems Biology; Hui Zhang, Institute for Systems Biology, Johns Hopkins University; Robin Lovell-Badge, U.K. National Institute of Medical Research; Steven R. Smith, Sanford-Burnham, Translational Research Institute, Florida Hospital; Fazli R. Awan, National Institute for Biotechnology and Genetic Engineering, Pakistan; Zhen Y. Jiang, Sanford-Burnham
About Sanford-Burnham Medical Research Institute
Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham takes a collaborative approach to medical research with major programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is recognized for its National Cancer Institute-designated Cancer Center and expertise in drug discovery technologies. Sanford-Burnham is a nonprofit, independent institute that employs 1,200 scientists and staff in San Diego (La Jolla), California and Orlando (Lake Nona), Florida. For more information, visit us at sanfordburnham.org.
White blood cell enzyme contributes to inflammation and obesity
An imbalance between an enzyme called neutrophil elastase and its inhibitor causes inflammation, obesity, insulin resistance, and fatty liver in mice and humans -- providing a new therapeutic target for these health conditions
2013-04-03
ELSE PRESS RELEASES FROM THIS DATE:
Fatty acid metabolite shows promise against cancer in mice
2013-04-03
(SACRAMENTO, Calif.) — A team of UC Davis scientists has found that a product resulting from a metabolized omega-3 fatty acid helps combat cancer by cutting off the supply of oxygen and nutrients that fuel tumor growth and spread of the disease.
The scientists report their discovery in the Proceedings of the National Academy of Sciences (PNAS). The groundbreaking study was a collaboration among multiple UC Davis laboratories and Harvard University.
The metabolite is epoxy docosapentaenoic acid (EDP), an endogenous compound produced by the human body from the omega-3 ...
An inside look at carnivorous plants
2013-04-03
When we imagine drama playing out between predators and prey, most of us picture stealthy lions and restless gazelle, or a sharp-taloned hawk latched on to an unlucky squirrel. But Ben Baiser, a post-doctoral fellow at the Harvard Forest and lead author of a new study in Oikos, thinks on a more local scale. His inter-species drama plays out in the humble bogs and fens of eastern North America, home to the carnivorous pitcher plant, Sarracenia purpurea. "It's shocking, the complex world you can find inside one little pitcher plant," says Baiser.
A pitcher plant's work ...
Rising temperature difference between hemispheres could dramatically shift tropical rain patterns
2013-04-03
One often ignored consequence of global climate change is that the Northern Hemisphere is becoming warmer than the Southern Hemisphere, which could significantly alter tropical precipitation patterns, according to a new study by climatologists from the University of California, Berkeley, and the University of Washington, Seattle.
Such a shift could increase or decrease seasonal rainfall in areas such as the Amazon, sub-Saharan Africa or East Asia, leaving some areas wetter and some drier than today.
"A key finding is a tendency to shift tropical rainfall northward, ...
Daily stress takes a toll on long-term mental health, UCI-led study finds
2013-04-03
Irvine, Calif., April 2, 2013 – Our emotional responses to the stresses of daily life may predict our long-term mental health, according to a new study led by a UC Irvine psychologist. The research, which appears online in the journal Psychological Science, suggests that maintaining emotional balance is crucial to avoiding severe mental health problems down the road.
Susan Charles, UC Irvine professor of psychology & social behavior, and her colleagues conducted the study in order to answer a long-standing question: Do everyday irritations add up to make the straw that ...
UC San Diego team achieves petaflop-level earthquake simulations on GPU-powered supercomputers
2013-04-03
A team of researchers at the San Diego Supercomputer Center (SDSC) and the Department of Electronic and Computer Engineering at the University of California, San Diego, has developed a highly scalable computer code that promises to dramatically cut both research times and energy costs in simulating seismic hazards throughout California and elsewhere.
The team, led by Yifeng Cui, a computational scientist at SDSC, developed the scalable GPU (graphical processing units) accelerated code for use in earthquake engineering and disaster management through regional earthquake ...
NRC panel advises US DOD on green buildings
2013-04-03
AMHERST, Mass. – New recommendations by a National Research Council (NRC) expert panel on green and sustainable building performance could lead to a revolution in building science by creating the first large building performance database, says panel member Paul Fisette, a nationally recognized sustainable building expert at the University of Massachusetts Amherst.
Fisette and six other NRC panel members were asked to consider whether nearly 500,000 structures owned by the U.S. Department of Defense (DOD) worldwide are being operated as sustainably and as efficiently ...
Pedestrians at serious risk when drivers are 'permitted' to turn left
2013-04-03
CORVALLIS, Ore. – A study to examine driver behavior in permitted left turns has identified what researchers call an "alarming" level of risk to pedestrians crossing the street – about 4-9 percent of the time, drivers don't even bother to look and see if there are people in the way.
As opposed to a "protected" left turn, in which a solid green arrow gives a driver the complete right of way in a left-turn lane, a "permitted" left turn is often allowed by a confusing hodgepodge of signals, and drivers may have to pick their way through narrow windows of oncoming traffic.
This ...
Targeting cholesterol buildup in eye may slow age-related vision loss
2013-04-03
Targeting cholesterol metabolism in the eye might help prevent a severe form of age-related macular degeneration (AMD), one of the most common causes of blindness in older Americans, according to indications in a study in mice, which was supported by the National Institutes of Health.
Cholesterol build-up in arteries and veins, or atherosclerosis, occurs as a natural consequence of aging. Likewise, in AMD, cholesterol is known to accumulate in the eye, within deposits called drusen.
The study, published in Cell Metabolism, shows that large cells called macrophages ...
Telerobotic system designed to treat bladder cancer better
2013-04-03
Although bladder cancer is the sixth most common form of cancer in the U.S. and the most expensive to treat, the basic method that doctors use to treat it hasn't changed much in more than 70 years.
An interdisciplinary collaboration of engineers and doctors at Vanderbilt and Columbia Universities intends to change that situation dramatically. Headed by Nabil Simaan, associate professor of mechanical engineering at Vanderbilt, the team has developed a prototype telerobotic platform designed to be inserted through natural orifices – in this case the urethra – that can provide ...
Cisplatin-resistant cancer cells sensitive to experimental anticancer drugs, PARP inhibitors
2013-04-03
PHILADELPHIA — Poly (ADP-ribose) polymerase inhibitors may be a novel treatment strategy for patients with cancer that has become resistant to the commonly used chemotherapy drug cisplatin, according to data from a preclinical study published in Cancer Research, a journal of the American Association for Cancer Research.
"Cisplatin is one of the most widely used conventional, anticancer chemotherapy drugs," said Guido Kroemer, M.D., Ph.D., professor at University Paris Descartes in Paris, France. "Unfortunately, most patients respond only transiently to cisplatin therapy ...
LAST 30 PRESS RELEASES:
Cost of copper must rise double to meet basic copper needs
A gel for wounds that won’t heal
Iron, carbon, and the art of toxic cleanup
Organic soil amendments work together to help sandy soils hold water longer, study finds
Hidden carbon in mangrove soils may play a larger role in climate regulation than previously thought
Weight-loss wonder pills prompt scrutiny of key ingredient
Nonprofit leader Diane Dodge to receive 2026 Penn Nursing Renfield Foundation Award for Global Women’s Health
Maternal smoking during pregnancy may be linked to higher blood pressure in children, NIH study finds
New Lund model aims to shorten the path to life-saving cell and gene therapies
Researchers create ultra-stretchable, liquid-repellent materials via laser ablation
Combining AI with OCT shows potential for detecting lipid-rich plaques in coronary arteries
SeaCast revolutionizes Mediterranean Sea forecasting with AI-powered speed and accuracy
JMIR Publications’ JMIR Bioinformatics and Biotechnology invites submissions on Bridging Data, AI, and Innovation to Transform Health
Honey bees navigate more precisely than previously thought
Air pollution may directly contribute to Alzheimer’s disease
Study finds early imaging after pediatric UTIs may do more harm than good
UC San Diego Health joins national research for maternal-fetal care
New biomarker predicts chemotherapy response in triple-negative breast cancer
Treatment algorithms featured in Brain Trauma Foundation’s update of guidelines for care of patients with penetrating traumatic brain injury
Over 40% of musicians experience tinnitus; hearing loss and hyperacusis also significantly elevated
Artificial intelligence predicts colorectal cancer risk in ulcerative colitis patients
Mayo Clinic installs first magnetic nanoparticle hyperthermia system for cancer research in the US
Calibr-Skaggs and Kainomyx launch collaboration to pioneer novel malaria treatments
JAX-NYSCF Collaborative and GSK announce collaboration to advance translational models for neurodegenerative disease research
Classifying pediatric brain tumors by liquid biopsy using artificial intelligence
Insilico Medicine initiates AI driven collaboration with leading global cancer center to identify novel targets for gastroesophageal cancers
Immunotherapy plus chemotherapy before surgery shows promise for pancreatic cancer
A “smart fluid” you can reconfigure with temperature
New research suggests myopia is driven by how we use our eyes indoors
Scientists develop first-of-its-kind antibody to block Epstein Barr virus
[Press-News.org] White blood cell enzyme contributes to inflammation and obesityAn imbalance between an enzyme called neutrophil elastase and its inhibitor causes inflammation, obesity, insulin resistance, and fatty liver in mice and humans -- providing a new therapeutic target for these health conditions